Premium
Patient follow‐up after discharge after COVID‐19 pneumonia: Considerations for infectious control
Author(s) -
Zheng Zhong,
Yao Zhixian,
Wu Ke,
Zheng Junhua
Publication year - 2020
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.25994
Subject(s) - covid-19 , pandemic , pneumonia , outbreak , medicine , coronavirus , intensive care medicine , virology , viral pneumonia , disease , infectious disease (medical specialty)
Coronavirus disease 2019 (COVID‐19) represents a significant global medical issue, with a growing number of cumulative confirmed cases. However, a large number of patients with COVID‐19 have overcome the disease, meeting hospital discharge criteria, and are gradually returning to work and social life. Nonetheless, COVID‐19 may cause further downstream issues in these patients, such as due to possible reactivation of the virus, long‐term pulmonary defects, and posttraumatic stress disorder. In this study, we, therefore, queried relevant literature concerning severe acute respiratory syndrome, Middle East respiratory syndrome, and COVID‐19 for reference to come to a consensus on follow‐up strategies. We found that strategies, such as the implementation of polymerase chain reaction testing, imaging surveillance, and psychological assessments, starting at the time of discharge, were necessary for long‐term follow‐up. If close care is given to every aspect of coronavirus management, we expect that the pandemic outbreak will soon be overcome.